Background: Growth impairment is the most common complication in patients with childhood-onset systemic lupus erythematosus (cSLE). There are limited data on risk factors affecting growth development in Asian patients with cSLE. This study aimed to determine the predictors of growth impairment in such patients. Methods: All SLE patients aged < 15 years diagnosed in Ramathibodi Hospital between 2006 and 2016 were enrolled in a retrospective cohort study. Baseline characteristics, including height, weight, clinical manifestations, disease activity score, and medications, were reviewed from medical records from the time at diagnosis to achievement of final adult height (FAH). Age at menarche in girls, adult voice appearance in boys, and parental height were collected by interview. Parent-adjusted FAH (PaFAH) Z-score was calculated as the difference between FAH Z-score for chronological age of the patients and their mid parental height-Z score. The patients were classified into two groups: (1) normal growth (PaFAH Z-score ≥ − 1.5, 2) growth impairment (PaFAH Z-score
CITATION STYLE
Ponin, L., Poomthavorn, P., Pirojsakul, K., Lerkvaleekul, B., Soponkanaporn, S., Chitrapazt, N., & Vilaiyuk, S. (2022). Long-term growth and final adult height outcome in childhood-onset systemic lupus erythematosus. Pediatric Rheumatology, 20(1). https://doi.org/10.1186/s12969-022-00663-0
Mendeley helps you to discover research relevant for your work.